
Pharmacally
Disease & Drugs
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Disease & Drugs
Drugs Safety AlertFDA Removes REMS Requirement for Caprelsa (Vandetanib)On September 25, 2025, the U.S. Food and Drug Administration (FDA) announced the removal of the Risk Evaluation and Mitigation Strategy (REMS) for Caprelsa (vandetanib).Fact-Checked
Clinical Trials“Permethrin-Treated Baby Wraps Against Malaria”Malaria remains one of the most devastating infectious diseases in Sub-Saharan Africa claim thousands of lives each year, where infants are among the most vulnerable.Fact-Checked
Clinical TrialsCan oral Semaglutide (Wegovy) 25 mg replace the Once-Weekly 2.4 mg Injection for Obesity?The OASIS-4 phase 3 trial conducted by Novo Nordisk and published in the New England Journal of Medicine shows that once-daily oral semaglutide 25 mg produces clinically significant…Fact-Checked
Drugs Safety AlertGlobal Acetaminophen and Autism Concerns: Controversy ExplainedGlobal health authorities, including the FDA, HHS, and WHO, are reviewing evidence on a possible link between acetaminophen (Tylenol) use during pregnancy and autism.Fact-Checked
Clinical TrialsRoche’s Phase 3 evERA Trial: Giredestrant Boosts Progression-Free Survival in ER-Positive Breast CancerRoche/Genentech’s phase 3 evERA trials found that Giredestrant plus everolimus significantly improved progression-free survival (PFS) versus standard-of-care endocrine therapy plus everolimus in patients with estrogen receptor-positive, human epidermal…Fact-Checked
New Drug ApprovalForzinity (Elamipretide) wins accelerated approval-the first FDA-approved therapy for Barth syndromeThe U.S. Food and Drug Administration (FDA) have granted accelerated approval to Forzinity (Elamipretide HCl) developed by Stealth Biotherapeutics as the first approved treatment for Barth syndrome.Fact-Checked
New Drug ApprovalProtecting the Tiny Lungs: Clesrovimab Brings New Hope against Respiratory Syncytial Virus (RSV)Respiratory Syncytial Virus (RSV) is one of the most significant threats to infant health worldwide.Fact-Checked
ResearchCan Mouth Bacteria Trigger Heart Attacks? New Research Says YesWhen we think about heart disease, we usually blame cholesterol buildup, high blood pressure, diabetes, obesity, or smoking.Fact-Checked
ResearchIndian State of Kerala Reports Brain-Eating Amoeba Cases: A rare infection sparks urgent public health responseKerala reports a rare outbreak of brain-eating amoeba (Naegleria fowleri), with 69 suspected cases and 19 deaths.Fact-Checked
New Drug ApprovalFDA Approves Enbumyst (bumetanide) Nasal Spray to Treat Edema from Heart, Liver and Kidney DiseaseOn September 14, 2025 the FDA approved Enbumyst an intranasal formulation of the loop diuretic bumetanide for short-term treatment of edema associated with congestive heart failure (CHF), hepatic…Fact-Checked
Clinical TrialsNovo Nordisk’s Cagrilintide shows promising weight loss in REDEFINE-1 sub-analysis, unveiled at EASD 2025Novo Nordisk presented new phase 3 data on cagrilintide, a once-weekly amylin analogue, at the European Association for the Study of Diabetes (EASD) congress which is happening in…Fact-Checked
ResearchFDA to Take Stricter Action on Misleading Drug Ads, Says CommissionerDirect-to-consumer drug advertising in the United States has become a major public health problem. In a recent JAMA commentary (September 2025), FDA Commissioner Dr. Martin A.Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.